SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways

Blood

Volumn 96, Issue 10, 2000, Pages 3422-3430

  Duarte, R F ^a   Frank, D A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P27; STAT1 PROTEIN; STAT3 PROTEIN; STEM CELL FACTOR;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

EID: 0034670022     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3422     Document Type: Article

References (81)

1. The Kit receptor and its ligand, Steel factor, as regulators of hemopoiesis
2. Stem cell factor is a potent synergistic factor in hematopoiesis
3. The in vitro and in vivo effects of stem cell factor on human hematopoiesis
4. Flt-3-ligand stimulates/co-stimulates the growth of myeloid stem/progenitor cells
5. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages
6. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis
7. The combination of Steel factor and GM-CSF blocks apoptosis induced by retinoic acid and upregulates AP-1 in a human growth factor-dependent cell line
8. Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, MO7e
9. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division
10. + progenitor celts from bone marrow and G-CSF-mobilized peripheral blood
11. Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo
12. Human thymocyte responsiveness to stem cell factor: Synergy with interleukin-2 for the generation of NK/LAK cytotoxicity
13. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells
14. Granulocytecolony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line
15. Recombinant rat stem cell factor synergises with recombinant human granulocyte-colony stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential
16. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates
17. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs
18. Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone
19. Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: A randomized, controlled trial
20. A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients
21. Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - Results of a phase I/II trial
22. Cytokine receptor signaling
23. Advances in understanding postreceptor signaling in response to granulocyte-colony stimulating factor
24. Steel locus defines new multipotent growth factor
25. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor
26. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus
27. Advances in understanding the postreceptor mechanisms of action of GM-CSF, G-CSF and Steel factor
28. Stem cell factor, the JAK-STAT pathway and signal transduction
29. Interleukin 2 signaling involves the phosphorylation of novel Stat proteins
30. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway
31. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues
32. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features
33. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
34. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus
35. Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor
36. Hematopoietic growth factors signal through the formation of reactive oxygen species
37. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor
38. Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo
39. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation
40. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
41. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
42. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
43. Cyclin-dependent regulation of G1 in mammalian fibroblasts
44. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
45. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation
46. WAF1, a potential mediator of p53 tumor suppression
47. Serum response factor: Transcriptional regulation of genes induced by growth factors and differentiation
48. Growth factor-induced gene expression: The ups and downs of c-fos regulation
49. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
50. Jaks and STATs: Biological implications
51. STAT signaling in the pathogenesis and treatment of cancer
52. The Jak-Stat pathway in normal and perturbed hematopoiesis
53. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression
54. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
55. Definition of a consensus sequence for peptJde substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase
56. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases
57. The functional synergy between IL-12 and IL-2 involves p38 MAP kinase and is associated with the augmentation of STAT serine phosphorylation
58. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein
59. Cloning of p27kip-1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals
60. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells
61. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor
62. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration
63. Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor
64. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Slat3, and p42, p44MAPK
65. Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells
66. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells
67. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response
68. Stem cell factor activates STAT-6 DNA binding in IL-3-derived bone marrow mast cells
69. Slat1 associates with c-kit and is activated in response to stem cell factor
70. STAT protein recruitment and activation in c-Kit deletion mutants
71. Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines
72. Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor
73. Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages
74. Requirement of serine phosphorylation for formation of STAT-promoter complexes
75. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation
76. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins
77. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases
78. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)
79. STAT3 is a serine kinase target in T lymphocytes: Interleukin 2 and T cell antigen receptor signals converge upon serine 727
80. Cytokine signal transduction in P19 embryonal carcinoma cells: Regulation of Stat3-mediated transactivation occurs independently of p21 ras-Erk signaling
81. p38 MAP kinase is required for STAT1 serine phosphorylalion and transcriptional activation induced by interferons